Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weipi Formula
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Weipi Formula is an herbal drug, specifically a Traditional Chinese Medicine compound, currently being investigated for its efficacy and safety in treating functional dyspepsia (FD) in adults. Clinical trials aim to assess its ability to reduce Traditional Chinese Medicine (TCM) syndrome scores and identify potential adverse effects. The drug is administered orally.
- Brand names
- Weipi Formula
- Other names
- Wu SiSi FormulaWeipi Formula
Beyond the preview
Go deeper on Weipi Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Weipi Formula.